FMD vaccine for pigs

Foot and Mouth Disease Vaccine, Inactivated

Foot and Mouth Disease (FMD) Vaccine, Inactivated (Type O, Strains O/Mya98/XJ/2010 and O/GX/09-7) is designed to prevent Type O FMD in pigs. This vaccine provides immunity for up to 6 months and is administered intramuscularly at the back of the ear root.

  • Vaccine Type: Inactivated Viral Vaccine
  • Target Species: Pigs
  • Indication / Application: Prevention of Foot-and-Mouth Disease (Type O)
  • Strain Coverage: O/Mya98 (SEA topotype) + O/GX variant strain
  • Immunity Duration: 6 months
  • Manufacturing: GMP-certified
  • Supply Mode: Bulk Supply / Distributor / OEM Available
  • Origin: China

    Inactivated FMD Vaccine Overview

    This vaccine is a bivalent inactivated Foot-and-Mouth Disease (FMD) vaccine specifically designed for pigs, targeting Type O strains prevalent in Asia, including:

    • O/Mya98/XJ/2010 (Southeast Asia topotype)
    • O/GX/09-7 (variant strain)

    Key Technical Features:

    • High antigen payload: ≥600 ng per strain per dose
    • Potency: ≥6 PD50 per dose (for each strain)
    • Virus content before inactivation: ≥10⁷.0 TCID50/mL

    Benefits:

    • Strong cross-protection against circulating Type O strains
    • Suitable for endemic and high-risk regions
    • Designed for intensive pig farming systems

    Immunization Program

    • Suitable for growing pigs and adult pigs
    • Can be used in routine vaccination programs and regional disease control strategies

    Dosage & Administration

    Route: Intramuscular injection

    • Injection Site: Behind the ear root
    Pig WeightDosage
    10–25 kg1 mL (½ dose)
    >25 kg2 mL (1 dose)

    Administration Notes:

    • Multi-point injection recommended for piglets
    • Use one needle per animal to prevent cross-contamination

    Composition

    • Inactivated FMD virus Type O (Strain O/Mya98/XJ/2010)
    • Inactivated FMD virus Type O (Strain O/GX/09-7)
    • Each strain ≥600 ng antigen per dose
    • Potency ≥6 PD50 per strain

    Product Characteristics

    • Light pink or milky white viscous emulsion
    • Stable oil-emulsion formulation for prolonged immunity

    Safety & Adverse Reactions

    General Reactions:

    • Mild swelling at injection site
    • Temporary fever
    • Reduced appetite for 1–2 days

    Severe (Rare) Reactions:

    • Hypersensitivity (respiratory distress, tremors, nasal bleeding)
    • Possible abortion in pregnant sows
    • Immediate treatment with epinephrine or dexamethasone required

    Precautions

    1. Store and transport at 2–8°C, do not freeze
    2. Avoid vaccination in:
      • Sick or weak pigs
      • Stressed animals (transport, environmental changes)
      • Late pregnancy (use with caution)
    3. Shake well and restore to room temperature before use
    4. Use aseptic injection techniques (one needle per pig)
    5. Vaccination should be performed by trained professionals
    6. Follow vaccination order:
      • Safe areas → Threatened areas → Endemic areas
    7. Movement of animals allowed 21 days after vaccination
    8. Maintain strict biosecurity measures (disinfection, quarantine)
    9. Keep detailed vaccination records
    10. Dispose of vaccine waste according to biosafety regulations

    Packaging & Specification

    • Specification: 100 mL/bottle
    • Packaging: 100 bottles/carton

    Storage & Shelf Life

    • Storage: 2–8°C, protect from light
    • Shelf Life: 24 months

    Contact us today to become a partner!

    Inquire Now

    Relate News

    Get a free quote

    Tell us what you need and we will get back to you within eight hours!

    CONTACT US

    Become our partner